Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q4 2025 holdings

Shares (Q4 2025)
9,075,153
Value
$7.00B
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of REGN by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20259,075,153$7.00B0.1%+26,884+0.3%AddedHolders
Q3 20259,048,269$5.09B0.1%−375,779−4.0%ReducedHolders
Q2 20259,424,048$4.95B0.1%+16,157+0.2%AddedHolders
Q1 20259,407,891$5.97B0.1%+121,545+1.3%AddedHolders
Q4 20249,286,346$6.61B0.1%−33,944−0.4%ReducedHolders
Q3 20249,320,290$9.80B0.2%+326,320+3.6%AddedHolders
Q2 20248,993,970$9.45B0.2%+63,729+0.7%AddedHolders
Q1 20248,930,241$8.60B0.2%+91,956+1.0%AddedHolders
Q4 20238,838,285$7.76B0.2%+39,780+0.5%AddedHolders
Q3 20238,798,505$7.24B0.2%−58,533−0.7%ReducedHolders
Q2 20238,857,038$6.36B0.2%+4,917+0.1%AddedHolders
Q1 20238,852,121$7.27B0.2%+129,673+1.5%AddedHolders
Q4 20228,722,448$6.29B0.2%+74,323+0.9%AddedHolders
Q3 20228,648,125$5.96B0.2%+77,380+0.9%AddedHolders
Q2 20228,570,745$5.07B0.1%+210,415+2.5%AddedHolders
Q1 20228,360,330$5.84B0.1%+201,815+2.5%AddedHolders
Q4 20218,158,515$5.15B0.1%+87,234+1.1%AddedHolders
Q3 20218,071,281$4.88B0.1%+101,621+1.3%AddedHolders
Q2 20217,969,660$4.45B0.1%−30,752−0.4%ReducedHolders
Q1 20218,000,412$3.79B0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.